PeptideStack
5.2kquestions
20kanswers
220users

What is the dead-space loss per draw with a 31G needle at 6.67 mg/mL?

Asked 25 Oct 2024Modified 21 months agoViewed 8.6k times
9

Details up front: a 31G needle · 6.67 mg/mL.

This should be a straightforward calculation and I keep getting two different answers.

The numbers are arbitrary; the method is what I am after.

What is the general form of this calculation?

dead-space
dead-space

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small…

117 questions
insulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

244 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
shareeditfollowflag
RT
askedrune_thoresen16k2825 Oct 2024
3Voting to keep this open — it is more specific than it first looks. – rhian_prydderch 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 8.6k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.